Profile for European Patent Office Patent: 1532149
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Netherlands | C300504 | ⤷ Start Trial |
| Sweden | 1190035-4 | ⤷ Start Trial |
| Lithuania | PA2011013 | ⤷ Start Trial |
| Estonia | C20110018 00046 | ⤷ Start Trial |
| Luxembourg | 91889 | ⤷ Start Trial |
| Denmark | CA 2011 00030 | ⤷ Start Trial |
| Lithuania | PA2011013,C1532149 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1532149
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
